- The power and potential of gene therapy
- The paradigm shift yielding vast societal benefit
- Highly dynamic marketplace, with tailwinds and headwinds
- Overcoming key challenges, ranging from platform, to medical, commercial and manufacturing
- Introducing Spark’s Gene Therapy Innovation Center: Roche’s flagship COE for gene therapy manufacturing globally
Chief Patient Supply Officer
As Spark Therapeutics’ Chief Patient Supply Officer, Chris Stevens leads a team of dedicated professionals working together in manufacturing and technical operations, supply chain, quality and compliance to deliver transformational therapies for patients globally. Chris is also responsible for capital investments, engineering, EHS, real estate and facilities management across the enterprise.
Since joining Spark in 2017, Chris has effectively led teams in several key areas, initially serving as Head of Manufacturing where he led the development of Spark’s manufacturing network through the filing and launch of Luxturna, the first approved gene therapy for genetic disease in both the US and EU. Later, Chris held the role of Asset General Manager, Hemophilia A where he had end to end responsibility for Spark’s Hem A program before being promoted to Head of Product Strategy where he led the team responsible for all programs in Spark’s portfolio. Chris was appointed Chief Patient Supply Officer for Spark in the fall of 2022.
With more than 25 years’ end to end leadership experience in gene therapy, biotech, pharmaceutical and consumer products industries, Chris is an industry veteran with deep expertise in designing and operating supply chains in complex regulatory environments, manufacturing science and technology, technology transfer, quality, compliance, product strategy and P&L management.
Prior to Spark, Chris led teams at GlaxoSmithKline (GSK) focused on strategy, operations and planning, as well as GMP clinical manufacturing operations including process transfer and cell banking. Earlier in his career he held roles of increasing responsibility at Bristol-Myers Squibb (BMS) in process engineering, manufacturing and supply chain in Massachusetts, Indiana and Puerto Rico.
Beyond his role with Spark, Chris currently serves as Vice President of the Board at A Haven – a non-profit family grief center in Chester County, Pennsylvania. He received his M.S. in Industrial Management from the University of Southern Indiana and a B.S. in Chemical Engineering from Purdue University.